Delivery Order SPE2DB24D2212-SPE2DB25FHQSC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,061.44 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Multaq is a cardiovascular medication used in the treatment of atrial fibrillation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $4,435.36. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award. The contract is scheduled for ultimate completion on August 6, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is a prescription...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $19,665.68 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. Multaq is an antiarrhythmic medication used in military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitively awarded, firm fixed-price delivery order, valued at $1,529.88, was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,550.46 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Multaq (dronedarone) is an antiarrhythmic medication used in the...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,985.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,170.01 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQSCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,947.74 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, supporting the military healthcare system's pharmaceutical supply requirements. This delivery order represents a single transaction within AmerisourceBergen Drug Corp's broader engagement with the federal government. The award is a child contract issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical vendor for military and veteran healthcare systems, regularly fulfilling federal medical procurement needs across multiple therapeutic domains through competitive delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/2/25 |